Investor · ANDOVER, MA
Mark Eldridge
Open Mark in the network graph →Filings
17
SEC Form D
Connections
62
co-filers
Capital
$960.6M
across filings
Active
Jul 2019
to May 2025
Most-connected co-filers (62)
Lars Johansson · NEW YORK, NY9 sharedAndrew Bull · ANDOVER, MA9 sharedDavid Bruner · ANDOVER, MA9 sharedMarc Cirrone · ANDOVER, MA8 sharedRiley Lyons · ANDOVER, MA7 sharedMel Carvill · St. Peter Port, Y76 sharedArindam Bhattacharjee · St. Peter Port, Y76 sharedRyan Johnson · BURLINGAME, CA6 sharedJulie A. Graverson · Milwaukee, WI6 sharedAlex Tong · BOSTON, MA6 sharedPeter C. Hames · St. Peter Port, Y76 sharedMario Solari · LONDON, United Kingdom6 sharedRandon A. Samelson · Colorado Springs, CO6 sharedNilda-Cintron A. Cortez · Milwaukee, WI6 sharedSean Donovan · ANDOVER, MA6 sharedAdam Wood · WALNUT CREEK, CA6 sharedBen Wood · WALNUT CREEK, CA6 sharedAnil Ranka · GANDHINAGAR, K76 sharedSteve Johnson · BOSTON, MA6 sharedXing Hu · LONDON, United Kingdom6 sharedSebastian Peters · LONDON, United Kingdom6 sharedJonathan Hunnicutt · ANDOVER, MA6 sharedRichard Mather · LONDON, United Kingdom6 sharedLeonidas Addimando · Conshohocken, PA5 shared
Recent filings (17)
Oscar Wilde Spirits, Inc.Jun 2025 · 8 co-filers$3.0MALKU Holdings, LLCMay 2025 · 34 co-filersALKU Holdings, LLCMay 2025 · 34 co-filersOscar Wilde Spirits, Inc.May 2024 · 8 co-filers$3.0MOscar Wilde Spirits, Inc.May 2024 · 8 co-filers$3.0MALKU Holdings, LLCMay 2024 · 35 co-filersALKU Holdings, LLCMay 2024 · 35 co-filers$960.6MALKU Holdings, LLCMay 2024 · 35 co-filersALKU Holdings, LLCMay 2024 · 35 co-filers$960.6MProvell Pharmaceuticals, LLCFeb 2024 · 2 co-filers$600KProvell Pharmaceuticals, LLCAug 2023 · 2 co-filers$1.0MGenesis Emerging Markets, L .P.Aug 2023 · 23 co-filersEmerging Markets Fund of the Genesis Group Trust for Employee Benefit PlansAug 2023 · 25 co-filersGenesis Emerging Markets Business TrustAug 2023 · 25 co-filersProvell Pharmaceuticals, LLCMar 2023 · 2 co-filers$2.0MProvell Pharmaceuticals, LLCJul 2022 · 2 co-filers$2.0MGenesis Emerging Markets, L .P.Jul 2022 · 32 co-filersGenesis Emerging Markets Business TrustJul 2022 · 33 co-filersEmerging Markets Fund of the Genesis Group Trust for Employee Benefit PlansJul 2022 · 34 co-filersProvell Pharmaceuticals, LLCJul 2019 · 1 co-filer$2.0M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →